We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2318:HKEXPing An Insurance (Group) Company of China, Ltd. Class H Analysis

Data as of 2026-05-22 - not real-time

HK$61.25

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Ping An (2318.HK) appears dramatically undervalued – the market price of HK$61.25 is far below the DCF‑derived fair value of roughly HK$466, implying an upside of over 35%. Its trailing PE of 7.34 is less than half the industry average (16.69) and the price‑to‑book is under 1.0, while the dividend yield sits at a healthy 4.98% with a modest 35% payout ratio, indicating ample cash to sustain distributions. Recent brand accolades – retaining the title of the world’s most valuable insurance brand in 2026 – reinforce its market positioning, and the company posted strong operating cash flow (HK$5.46 tn) and free cash flow (HK$527 bn).
Technically, the stock trades above its 20‑day SMA (62.89) and 50‑day SMA (61.98) with a bullish trend direction, yet the MACD has turned bearish and RSI is neutral at 42.7, suggesting short‑term caution. Volume is tapering and volatility remains elevated (~27% 30‑day), but the low beta (0.61) tempers systematic risk. Overall, the fundamentals and valuation gap outweigh the near‑term technical headwinds.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Valuation gap of >35% versus DCF fair value
  • Strong cash generation supporting dividend and buy‑backs
  • Technical support around HK$59.75 limiting downside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained low PE relative to peers
  • Brand leadership and expanding fintech/asset‑management platforms
  • Stable earnings outlook with forward PE of 5.6

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Durable competitive moat in Chinese insurance and financial services
  • Consistent dividend yield and low payout ratio ensuring sustainability
  • Long‑term demographic tailwinds and rising wealth in China

Key Metrics & Analysis

Financial Health

Revenue Growth-3.30%
Profit Margin13.94%
P/E Ratio7.3
ROE11.28%
ROA0.98%
Debt/Equity140.54
P/B Ratio0.9
Op. Cash FlowHK$546.5B
Free Cash FlowHK$527.7B
Industry P/E16.7

Technical Analysis

TrendBullish
RSI42.7
SupportHK$59.75
ResistanceHK$66.50
MA 20HK$62.89
MA 50HK$61.98
MA 200HK$61.11
MACDBearish
VolumeDecreasing
Fear & Greed Index91.5

Valuation

Fair ValueHK$466.41
Target PriceHK$82.72
Upside/Downside35.05%
GradeUndervalued
TypeValue
Dividend Yield4.98%

Risk Assessment

Beta0.61
Volatility26.75%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.